NGR4 and ERBB4 as Promising Diagnostic and Therapeutic Targets for Metabolic Disorders.
Vulf M, Bograya M, Komar A, Khaziakhmatova O, Malashchenko V, Yurova K, Sirotkina A, Minchenko A, Kirienkova E, Gazatova N, et al. Front Biosci (Elite Ed). 2023 Jun 6; 15(2):14.